Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lierni Fernández"'
Autor:
Clara Maluquer, Beatriz Bellosillo, Alberto Mussetti, Eva Domingo‐Domènech, Rocío Parody, Lierni Fernández‐Ibarrondo, Roser Velasco, Gabriel Moreno‐González, Gabriela Sanz, Montserrat Cortés, Anna Sureda
Publikováno v:
eJHaem, Vol 2, Iss 1, Pp 109-111 (2021)
Abstract Objectives Chimeric antigen receptor T cells (CARTs) against CD19 antigen represent an effective therapy for relapsed/refractory diffuse large B‐cell lymphoma (rrDLBCL). There is no diagnostic test able to predict which patients with resid
Externí odkaz:
https://doaj.org/article/6b9fc4c9d5e0415d90b78b4c8e0aa114
Autor:
Juan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, Ramón Diez-Feijóo, Sergio Pinzón, Joan Gibert, Lierni Fernández-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sánchez-González, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. García, Lluis Colomo, Beatriz Bellosillo, Antonio Gutiérrez, Antonio Salar
Publikováno v:
Blood Advances. 7:1606-1614
Several clinical risk models have been proposed to predict the outcome of follicular lymphoma (FL). The development of next-generation sequencing technologies has allowed the integration of somatic gene mutations into clinical scores to build genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a7efb2fbd4408b7ce5027e317e42de
https://doi.org/10.1182/bloodadvances.2022007949
https://doi.org/10.1182/bloodadvances.2022007949
Autor:
Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan Jose Rodriguez-Sevilla, Concepción Fernández-Rodríguez, Sara Garcia-Avila, Patricia Velez, Joan Gibert, Lierni Fernández-Ibarrondo, Antonio Salar, Lourdes Florensa, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo
Publikováno v:
Leukemia. 36:2922-2926
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97ca855b85fc4f80234c3bd48a3071a
https://doi.org/10.1038/s41375-022-01733-8
https://doi.org/10.1038/s41375-022-01733-8
Autor:
Nieves Garcia-Gisbert, Sara Garcia-Ávila, Brayan Merchán, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Ramon M. Pujol, Marcio Andrade-Campos, Leonor Arenillas, Antonio Salar, Xavier Calvo, Carles Besses, Beatriz Bellosillo
Publikováno v:
Blood Advances. 6:3178-3188
Molecular and cytogenetic studies are essential for diagnosis and prognosis in patients with myelodysplastic syndromes (MDSs). Cell-free DNA (cfDNA) analysis has been reported to be a reliable noninvasive approach for detecting molecular abnormalitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e1615c3e869303f9b4eebffe4c4a9e
https://doi.org/10.1182/bloodadvances.2021006565
https://doi.org/10.1182/bloodadvances.2021006565
Autor:
Juan Jose, Rodríguez-Sevilla, Concepción, Fernández-Rodríguez, Leyre, Bento, Ramón, Diez-Feijóo, Sergio Felipe, Pinzon, Joan, Gibert, Lierni, Fernández-Ibarrondo, Marta, Lafuente, Ana, Ferrer, Blanca, Sanchez-Gonzalez, Eva, Gimeno, Juan, Sainz, Rafael, Ramos-Asensio, Juan F, Garcia, Lluis, Colomo, Beatriz, Bellosillo, Antonio, Gutierrez, Antonio, Salar-Silvestre
Publikováno v:
Blood advances.
Several clinical risk models have been proposed to predict outcome in follicular lymphoma (FL). The development of Next Generation Sequencing (NGS) technologies has allowed the integration of somatic gene mutations in clinical scores to build genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f76626c9fa1fd7f3f5b50beacc6b0f34
https://pubmed.ncbi.nlm.nih.gov/36260737
https://pubmed.ncbi.nlm.nih.gov/36260737
Autor:
Laura, Lo Riso, Gardenia, Vargas-Parra, Gemma, Navarro, Leonor, Arenillas, Lierni, Fernández-Ibarrondo, Beatriz, Robredo, Carmen, Ballester, Bernardo, López, Albert, Perez-Montaña, Antonia, Sampol, Lourdes, Florensa, Carles, Besses, María Antonia, Duran, Beatriz, Bellosillo
Publikováno v:
Genes. 13(10)
Primary familial and congenital polycythemia is a rare disease characterized by an increase in red cell mass that may be due to pathogenic variants in the EPO receptor (iEPOR/i) gene. To date, 33 genetic variants have been reported to be associated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63b6d0a65a178fe54a7178c5e0c53566
https://pubmed.ncbi.nlm.nih.gov/36292571
https://pubmed.ncbi.nlm.nih.gov/36292571
Autor:
Laura Camacho, Concepción Fernández-Rodríguez, Álvaro Taus, Joan Albanell, Ainhoa Hernandez, Pedro P. Rocha, Sergi Clavé, Lierni Fernández-Ibarrondo, Beatriz Bellosillo, M. Hardy-Werbin, Edurne Arriola, Marta Salido, Raquel Longarón
Publikováno v:
Archivos de Bronconeumología. 57:323-329
Introduction KRAS is the most common driver mutation in lung cancer. ctDNA-based assessment offers advantages over tumor as a minimally invasive method able to capture tumor heterogeneity. Monitoring KRAS mutational load in ctDNA may be useful in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5b5a1ae60c8d7b6a889680232e356a
https://doi.org/10.1016/j.arbres.2020.01.023
https://doi.org/10.1016/j.arbres.2020.01.023
Autor:
Nieves Garcia-Gisbert, Concepción Fernández-Rodríguez, Anna Angona, Marcio Andrade-Campos, Carlos Besses, Lierni Fernández-Ibarrondo, Beatriz Bellosillo, Leonor Arenillas, Antonio Salar, Xavier Calvo, Raquel Longarón, Laura Camacho, Joan Gibert
Publikováno v:
British Journal of Haematology. 192:300-309
Genetic studies in patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) are essential to establish the correct diagnosis and to optimise their management. Recently, it has been demonstrated that it is possible to detect molecular a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cae39613442de6520acd96c03049e68e
https://doi.org/10.1111/bjh.17087
https://doi.org/10.1111/bjh.17087
Autor:
Antonio Gutierrez, Antonio Salar, Maria Concpcion Fernandez, Ramon Diez-Feijoo, Lierni Fernández-Ibarrondo, Beatriz Bellosillo, Eva Gimeno, Leyre Bento, Juan F. García, Montserrat García-Retortillo, Juan-Manuel Sancho, Luis Colomo, Blanca Sanchez-Gonzalez, Juan José Rodríguez-Sevilla, Laura Camacho, Joan Gibert
Publikováno v:
Blood Advances
Key Points Patients with FL anti-HBc+ present with worse 10-year PFS and OS.Patients with anti-HBc+ present with a higher frequency of ARID1A mutations and lack of EP300 mutations.
Epidemiological studies have demonstrated the association betwee
Epidemiological studies have demonstrated the association betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a745d3b34ac8bbbddcc4127a345b113
https://ddd.uab.cat/record/270507
https://ddd.uab.cat/record/270507
Autor:
Laura Lo Riso, Gardenia Vargas-Parra, Gemma Navarro, Leonor Arenillas, Lierni Fernández-Ibarrondo, Beatriz Robredo, Carmen Ballester, Bernardo López, Albert Perez-Montaña, Antonia Sampol, Lourdes Florensa, Carles Besses, María Antonia Duran, Beatriz Bellosillo
Publikováno v:
Genes. 13:1686
Primary familial and congenital polycythemia is a rare disease characterized by an increase in red cell mass that may be due to pathogenic variants in the EPO receptor (EPOR) gene. To date, 33 genetic variants have been reported to be associated. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbc70ea3df4fd53aaf4a3bc8e5f282ea
https://doi.org/10.3390/genes13101686
https://doi.org/10.3390/genes13101686